https://www.business-standard.com/article/economy-policy/powerful-lobbying-in-us-against-india-s-covid-vaccine-ip-waiver-push-121052600626_1.html

By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.

Web Exclusive

While big pharma has vehemently opposed India's move on compulsory licensing, even non-pharma influencers such as Bill Gates are against sharing vaccine technology without patenting

https://s3-us-west-2.amazonaws.com/secure.notion-static.com/6cc34eb9-9f69-4294-bd9b-4be4c8793915/1621501119-6948.jpg

Photo: Shutterstock

In 1952, when American virologist Jonas Salk discovered the first polio vaccine, he was asked why did he not patent it. The patent for a disease that was debilitating thousands of children every year across the globe belonged to the people, said Salk. “Could you patent the sun?” he asked.

Key stories on business-standard.com are available to premium subscribers only. Already a premium subscriber? LOGIN NOW

SUBSCRIBE TO INSIGHTS

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Latest News

MOST POPULAR

From BS Website

About us

Support & Contact

Reader Centre

BS Products

Connect with BS